Natera (45E) Stock Forecast & Price Target

4 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

45E Analyst Ratings

Strong Buy

20 Buy

1 Hold

0 Sell

Based on 21 analysts giving stock ratings to

Natera

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

45E Stock 12 Month Forecast

Average Price Target

€335.24

▲(20.72% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is €335.24 with a high forecast of €427.82 and a low forecast of €285.21. The average price target represents a 20.72% change from the last price of €277.70.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"157":"€157","428":"€428","224.75":"€224.8","292.5":"€292.5","360.25":"€360.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":427.8193056,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€427.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":335.2423977489474,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€335.24</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":285.2128704,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€285.21</span>\n  </div></div>","useHTML":true}}],"tickPositions":[157,224.75,292.5,360.25,428],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,373.7,377.8630235076923,382.0260470153846,386.1890705230769,390.35209403076925,394.51511753846154,398.6781410461538,402.84116455384617,407.00418806153846,411.16721156923074,415.3302350769231,419.4932585846154,423.6562820923077,{"y":427.8193056,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,373.7,370.74172290376515,367.78344580753037,364.82516871129553,361.86689161506075,358.9086145188259,355.9503374225911,352.9920603263563,350.03378323012146,347.0755061338866,344.11722903765184,341.158951941417,338.2006748451822,{"y":335.2423977489474,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,373.7,366.8932977230769,360.0865954461538,353.2798931692308,346.4731908923077,339.6664886153846,332.8597863384615,326.05308406153847,319.2463817846154,312.4396795076923,305.6329772307692,298.8262749538461,292.0195726769231,{"y":285.2128704,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":158,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":197,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":191,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.4,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.8,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.8,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":277.5,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":373.7,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€427.82

Average Price Target€335.24

Lowest Price Target€285.21

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Patrick B Donnelly

Citi

€325.32→€427.82

Buy

54.06%

Upside

Reiterated

10/06/26

Natera price target raised to $480 from $365 at CitiNatera price target raised to $480 from $365 at Citi

Subbu Nambi

Guggenheim

€320.86→€423.36

Buy

52.45%

Upside

Reiterated

10/01/26

Natera price target raised to $475 from $360 at GuggenheimNatera price target raised to $475 from $360 at Guggenheim

Luke Sergott

Barclays

€303.04

Buy

9.12%

Upside

Reiterated

09/25/26

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (NASDAQ: LGND), Natera (NASDAQ: NTRA) and Aveanna Healthcare Holdings (NASDAQ: AVAH)

Eve Burstein

Bernstein

€325.32

Buy

17.15%

Upside

Reiterated

09/25/26

Natera (NTRA) Receives a Buy from Bernstein

Dan Leonard

RBC Capital

€311.95→€409.99

Buy

47.64%

Upside

Reiterated

09/24/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Evie Koslosky

Goldman Sachs

€258.47→€334.23

Hold

20.36%

Upside

Reiterated

09/20/26

Goldman Sachs Keeps Their Hold Rating on Natera (NTRA)

Kallum Titchmarsh

Morgan Stanley

€316.41

Buy

13.94%

Upside

Reiterated

09/14/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Natera (NASDAQ: NTRA) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Doug Schenkel

UBS

€258.47→€387.71

Buy

39.62%

Upside

Reiterated

09/09/26

Natera assumed with a Buy at UBSNatera assumed with a Buy at UBS

Jamie Clark

Rothschild & Co Redburn

€343.15

Buy

23.57%

Upside

Initiated

09/08/26

Natera initiated with a Buy at Rothschild & Co RedburnNatera initiated with a Buy at Rothschild & Co Redburn

David Westenberg

Piper Sandler

€323.98

Buy

16.67%

Upside

Reiterated

08/24/26

Analysts Conflicted on These Healthcare Names: Natera (NASDAQ: NTRA), Healthequity (NASDAQ: HQY) and CSPC Pharmaceutical Group (Other OTC: CHJTF)

Tycho Peterson

Jefferies

€294.13

Buy

5.91%

Upside

Reiterated

08/17/26

Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG) and Natera (NASDAQ: NTRA)

Unknown Analyst

Stephens

Not Ranked

Stephens

€311.95

Buy

12.33%

Upside

Reiterated

08/12/26

Stephens Keeps Their Buy Rating on Natera (NTRA)

Daniel Brennan

TD Cowen

€289.67→€303.04

Buy

9.12%

Upside

Assigned

08/07/26

Analysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Natera (NTRA)

Kyle Mikson CFA

Canaccord Genuity

€294.13→€334.23

Buy

20.36%

Upside

Reiterated

08/07/26

Natera price target raised to $375 from $330 at CanaccordNatera price target raised to $375 from $330 at Canaccord

Matt Larew

William Blair

―

Buy

―

Reiterated

08/07/26

Natera Earns Buy Rating on Surging Signatera Demand, Raised Revenue Outlook, and Multi‑Year Growth Visibility

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Patrick B Donnelly

Citi

€325.32→€427.82

Buy

54.06%

Upside

Reiterated

10/06/26

Natera price target raised to $480 from $365 at CitiNatera price target raised to $480 from $365 at Citi

Subbu Nambi

Guggenheim

€320.86→€423.36

Buy

52.45%

Upside

Reiterated

10/01/26

Natera price target raised to $475 from $360 at GuggenheimNatera price target raised to $475 from $360 at Guggenheim

Luke Sergott

Barclays

€303.04

Buy

9.12%

Upside

Reiterated

09/25/26

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (NASDAQ: LGND), Natera (NASDAQ: NTRA) and Aveanna Healthcare Holdings (NASDAQ: AVAH)

Eve Burstein

Bernstein

€325.32

Buy

17.15%

Upside

Reiterated

09/25/26

Natera (NTRA) Receives a Buy from Bernstein

Dan Leonard

RBC Capital

€311.95→€409.99

Buy

47.64%

Upside

Reiterated

09/24/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Evie Koslosky

Goldman Sachs

€258.47→€334.23

Hold

20.36%

Upside

Reiterated

09/20/26

Goldman Sachs Keeps Their Hold Rating on Natera (NTRA)

Kallum Titchmarsh

Morgan Stanley

€316.41

Buy

13.94%

Upside

Reiterated

09/14/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Natera (NASDAQ: NTRA) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Doug Schenkel

UBS

€258.47→€387.71

Buy

39.62%

Upside

Reiterated

09/09/26

Natera assumed with a Buy at UBSNatera assumed with a Buy at UBS

Jamie Clark

Rothschild & Co Redburn

€343.15

Buy

23.57%

Upside

Initiated

09/08/26

Natera initiated with a Buy at Rothschild & Co RedburnNatera initiated with a Buy at Rothschild & Co Redburn

David Westenberg

Piper Sandler

€323.98

Buy

16.67%

Upside

Reiterated

08/24/26

Analysts Conflicted on These Healthcare Names: Natera (NASDAQ: NTRA), Healthequity (NASDAQ: HQY) and CSPC Pharmaceutical Group (Other OTC: CHJTF)

Tycho Peterson

Jefferies

€294.13

Buy

5.91%

Upside

Reiterated

08/17/26

Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG) and Natera (NASDAQ: NTRA)

Unknown Analyst

Stephens

Not Ranked

Stephens

€311.95

Buy

12.33%

Upside

Reiterated

08/12/26

Stephens Keeps Their Buy Rating on Natera (NTRA)

Daniel Brennan

TD Cowen

€289.67→€303.04

Buy

9.12%

Upside

Assigned

08/07/26

Analysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Natera (NTRA)

Kyle Mikson CFA

Canaccord Genuity

€294.13→€334.23

Buy

20.36%

Upside

Reiterated

08/07/26

Natera price target raised to $375 from $330 at CanaccordNatera price target raised to $375 from $330 at Canaccord

Matt Larew

William Blair

―

Buy

―

Reiterated

08/07/26

Natera Earns Buy Rating on Surging Signatera Demand, Raised Revenue Outlook, and Multi‑Year Growth Visibility

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

KURAKura Oncology

DNLIDenali Therapeutics

OVIDOvid Therapeutics

HITIHigh Tide

AXGNAxoGen

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

3 Months

Catherine Ramsey SchulteRobert W. Baird

Success Rate

29/41 ratings generated profit

Average Return

+14.95%

Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 70.73% of your transactions generating a profit, with an average return of +14.95% per trade.

1 Year

Daniel BrennanTD Cowen

Success Rate

21/21 ratings generated profit

Average Return

+79.77%

Copying Daniel Brennan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +79.77% per trade.

2 Years

Puneet SoudaLeerink Partners

Success Rate

34/34 ratings generated profit

Average Return

+179.25%

Copying Puneet Souda's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +179.25% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

45E Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 45E has received 28 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 45E average Analyst price target in the past 3 months is 335.24.

Each month's total comprises the sum of three months' worth of ratings.

45E Financial Forecast

45E Earnings Forecast

Next quarter’s earnings estimate for 45E is -€0.21 with a range of -€0.54 to €0.12. The previous quarter’s EPS was -€0.42. 45E beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 45E has Performed in-line its overall industry.

45E Sales Forecast

Next quarter’s sales forecast for 45E is €630.86M with a range of €603.35M to €647.79M. The previous quarter’s sales results were €670.92M. 45E beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 45E has Performed in-line its overall industry.

45E Stock Forecast FAQ

What is DE:45E’s average 12-month price target, according to analysts?

Based on analyst ratings, Natera’s 12-month average price target is 335.24.

What is DE:45E’s upside potential, based on the analysts’ average price target?

Natera has 20.72% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Natera a Buy, Sell or Hold?

Natera has a consensus rating of Strong Buy, which is based on 20 buy ratings, 1 hold ratings and 0 sell ratings.

What is Natera’s share price target?

The average share price target for Natera is 335.24. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €427.82 ,and the lowest forecast is €285.21. The average share price target represents 20.72% Increase from the current price of €277.7.

What do analysts say about Natera?

Natera’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of Natera?

To buy shares of DE:45E, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Natera (45E) Stock Forecast & Price Target

45E Analyst Ratings

45E Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Natera

45E Analyst Recommendation Trends

45E Financial Forecast

45E Earnings Forecast

45E Sales Forecast

45E Stock Forecast FAQ

Detailed List of Analyst Forecasts